Jesper Lau博士在南丹麦大学完成生物学和化学的学习，1990年获得博士学位后曾在美国斯坦福大学B. Trost博士的实验室访学，尔后加入诺和诺德公司。1995年，Jesper Lau博士负责实施组合化学策略，并于2002年成立了一个新的部门旨在研究提高蛋白和多肽类药物的疗效。Lau博士在小分子和蛋白类药物的发现方面具有丰富的经验，他成功帮助研制了长效胰高血糖素样肽-1，是索马鲁肽的首要发明人。
Dr. Jesper Lau studied biology and chemistry at University of Southern Denmark. After receiving his Ph.D. degree in 1990 and a research visit stay at Dr. B. Trost’s laboratory in Standford University (U.S.A.), he joined Novo Nordisk. In 1995 he became responsible for implementing combinatorial chemistry strategy and in 2002 he established a new department to improve therapeutic properties of peptides and proteins. Dr. Lau has a broad experience in both small molecule and protein drug discovery. He was instrumental to the successful development of once weekly glucagon-like peptide-1 and is the first inventor of semaglutide.
课件：introduction to protein engineering.pdf